跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 98,970 条关于
“BCG-unresponsive bladder cancer”
全部
98,970
临床试验
80,106
药物
2,827
机构
1,132
资讯
14,905
去年
Cretostimogene Grenadenorepvec Shows Promise in BCG-Unresponsive Bladder Cancer
去年
Cretostimogene Shows Durable Responses in High-Risk Bladder Cancer
5个月前
ImmunityBio Secures $100 Million in Financing to Support Global Expansion of ANKTIVA Immunotherapy
去年
FDA Approves Ferring Pharmaceuticals' New Manufacturing Facility for Bladder Cancer Gene Therapy ADSTILADRIN
去年
Gene Therapy Shows Promise in BCG-Unresponsive Bladder Cancer Treatment
去年
Nadofaragene Firadenovec Shows Promise in BCG-Unresponsive Bladder Cancer, Reducing Cystectomy Rates
3年前
Phase II Study Evaluates Durvalumab for BCG-Unresponsive Bladder Cancer
9个月前
EMA Recommends Conditional Approval for ImmunityBio's Anktiva in BCG-Unresponsive Bladder Cancer
去年
Theralase's Light-Activated Ruvidar Shows Promising Results in BCG-Unresponsive Bladder Cancer Clinical Trial
去年
ImmVira Initiates Phase II Trial for Novel Oncolytic Immunotherapy in BCG-Unresponsive Bladder Cancer
第 1 页，共 1491 页
上一页
下一页
